Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-028675
Filing Date
2022-05-12
Accepted
2022-05-12 20:00:54
Documents
1
Period of Report
2022-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6042
  Complete submission text file 0001209191-22-028675.txt   7334
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Tross Stuart A (Reporting) CIK: 0001589641 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50865 | Film No.: 22919712